Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT00115076 · COMPLETED
Trial details
- NCT number
- NCT00115076
- Sponsor
- Rockefeller University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-04
- Primary completion
- 2009-05-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.